We are pleased to announce that the activities on synthetic CBD at our Farmabios site are progressing smoothly. The API is produced at a commercial batch size using a THC-free route, allowing us to satisfy high customer demands. As extension to the existing EU- and US-DMF for our pharmaceutical grade CBD, a Novel Food dossier has just been submitted to EFSA/EU. Approval expected mid-2021. The additional market applications are various within nutrition, cosmetics & healthcare – reach out to our Sales and BD team for more information!
Stockfoto # 1427893007
